A global multiple ascending dose study of insulin tregopil in patients with type 1 diabetes.

Trial Profile

A global multiple ascending dose study of insulin tregopil in patients with type 1 diabetes.

Planning
Phase of Trial: Phase I

Latest Information Update: 12 Sep 2017

At a glance

  • Drugs Insulin tregopil (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Biocon
  • Most Recent Events

    • 12 Sep 2017 New trial record
    • 06 Sep 2017 According to a Biocon media release, the company announced a partnership with Juvenile Diabetes Research Foundation (JDRF) to support a global multiple ascending dose study.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top